Prevalence and risk factors of antibodies towards HLA Class I and Class II in Malaysian renal transplant candidates

Autor: Norfarhana Khairul-Fahmy, Jamiila Ismail, Bee Tee Koay, Muhammad Zhafri Md-Zakariah, Salawati Mansor, Nordalila Zulkifli, Siti Fatimah Mat-Ali, Rozinah Mohamed, Norhazlin Mustafa, Masita Arip

Publikováno v: BMC Nephrology, Vol 24, Iss 1, Pp 1-6 (2023)

Abstract Antibody-mediated rejection (AMR) still persists as the major hurdle towards successful renal allograft survival. This paper aims to report on the HLA antibody landscape of renal transplant candidates in Malaysia. A total of 2,219 adult samp

Externí odkaz: https://doaj.org/article/f354c08d65694701b7830a2d4a7d15f9

Antibody against Human Leukocyte Antigens in female blood donors with and without previous abortion

Autor: Mahboobeh Mostakhdemin, Mojgan Shaiegan, Leila Kasraeian, Atiyeh Khosravi, Fatemeh Yari, Shahrzad Shayegan

Publikováno v: Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, Vol 21, Iss 12, Pp 85-93 (2019)

Introduction: Antibodies against Human leukocyte antigen (HLA) is produced following blood transfusion, pregnancy or organ transplants. These antibodies are involved in abortion and even present in non-allommunized healthy people. Anti-HLA antibodies

Externí odkaz: https://doaj.org/article/51f90124c3f54d95a69e33889a67d697

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients

Autor: Ilse Weinreich, Mats Bengtsson, Jouni Lauronen, Christian Naper, Kaie Lokk, Ilkka Helanterä, Margrét Birna Andrésdóttir, Søren Schwartz Sørensen, Lars Wennberg, Anna Varberg Reisæter, Bjarne Møller, Pernille Koefoed-Nielsen

Publikováno v: Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisaeter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182
Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisæter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program—10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182

In March 2009, the Scandiatransplant acceptable mismatch program (STAMP) was introduced as a strategy toward improving kidney allocation to highly sensitized patients. Patients with a transplantability score ≤ 2% are potential candidates for the pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8bae2e2efc070136ecc3dba03d10494
http://hdl.handle.net/10138/354246

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.